| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 5481 | 5734 | 6000 | 6542 |
| Cost of Material Consumed | 2836 | 2443 | 2538 | 2756 |
| Change in Inventory | -181 | -56 | -76 | 18 |
| Gross Margins | 51.56 | 58.37 | 58.97 | 57.6 |
| Employee Benefit Expenses | 1659 | 2011 | 2165 | 2176 |
| Other Expenses | 833 | 932 | 926 | 1001 |
| EBITDA | 334 | 404 | 447 | 591 |
| OPM | 6.09 | 7.05 | 7.45 | 9.03 |
| Other Income | 64 | 72 | 61 | 89 |
| Finance Cost | 27 | 26 | 39 | 57 |
| D&A | 138 | 129 | 143 | 175 |
| EBIT | 196 | 275 | 304 | 416 |
| EBIT Margins | 3.58 | 4.8 | 5.07 | 6.36 |
| PBT | 373 | 321 | 326 | 448 |
| PBT Margins | 6.81 | 5.6 | 5.43 | 6.85 |
| Tax | 98 | 61 | 69 | 139 |
| PAT | 275 | 260 | 257 | 309 |
| NPM | 5.02 | 4.53 | 4.28 | 4.72 |
| EPS | 47.83 | 45.22 | 44.7 | 53.74 |
| Financial Ratios | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating Profit Margin | 6.09 | 7.05 | 7.45 | 9.03 |
| Net Profit Margin | 5.02 | 4.53 | 4.28 | 4.72 |
| Earning Per Share (Diluted) | 47.83 | 45.22 | 44.7 | 53.74 |
| Assets | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed Assets | 344 | 252 | 805 | 793 |
| CWIP | 27 | 115 | 25 | 8 |
| Investments | 136 | 5 | 5 | 134 |
| Trade Receivables | 750 | 145 | 955 | 1122 |
| Inventory | 686 | 718 | 824 | 829.5 |
| Other Assets | 2401.5 | 2005.5 | 1302 | 1185.5 |
| Total Assets | 4344.5 | 3240.5 | 3916 | 4072 |
| Liabilities | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Share Capital | 57.5 | 57.5 | 57.5 | 57.5 |
| FV | 10 | 10 | 10 | 10 |
| Reserves | 2220 | 1234 | 1432 | 1746 |
| Borrowings | 0 | 0 | 0 | 0 |
| Trade Payables | 746 | 717 | 720 | 704.5 |
| Other Liabilities | 1321 | 1232 | 1706.5 | 1564 |
| Total Liabilities | 4344.5 | 3240.5 | 3916 | 4072 |
| Cash-Flow Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| PBT | 357 | 320 | 327 | 448 |
| OPBWC | 343 | 420 | 497 | 635 |
| Change in Receivables | -174 | 28 | -62 | -272.1 |
| Change in Inventories | -330 | -32 | -106 | -5.5 |
| Change in Payables | 378 | 10 | 507 | -87.4 |
| Other Changes | -1 | 2 | 0 | 0 |
| Working Capital Change | -127 | 8 | 339 | -365 |
| Cash Generated From Operations | 216 | 428 | 836 | 270 |
| Tax | -84 | -87 | -100 | -142 |
| Cash Flow From Operations | 132 | 341 | 736 | 128 |
| Purchase of PPE | -157 | -125 | -605 | -98 |
| Sale of PPE | 104 | 3.2 | 0 | 4.2 |
| Cash Flow From Investment | 168 | -51.8 | -583 | -64 |
| Borrowing | 0 | 0 | 0 | 0 |
| Dividend | -17 | -1294 | 0 | 0 |
| Equity | 0 | 0 | 0 | 0 |
| Others From Financing | -98 | -98 | -92 | -90 |
| Cash Flow from Financing | -115 | -1392 | -92 | -90 |
| Net Cash Generated | 385 | -1102.8 | 61 | -26 |
| Cash at the Start | 931 | 1315 | 212 | 273 |
| Cash at the End | 1316 | 212.2 | 273 | 247 |
Philips India Limited, a subsidiary of the global healthcare and consumer technology leader Koninklijke Philips N.V., is one of India’s most respected and diversified companies in the medical technology and consumer products space. The company operates across key segments including healthcare systems, personal health, and connected care, offering solutions such as diagnostic imaging, patient monitoring systems, healthcare informatics, grooming products, and household appliances. With decades of presence in India, Philips has built a strong brand reputation centered around innovation, quality, and customer trust. Its deep relationships with hospitals, clinics, retailers, and distributors reinforce its position as a leading name in both the healthcare and consumer domains.
From a business perspective, Philips India has been focusing heavily on digital health transformation, AI-enabled diagnostics, and integrated healthcare solutions—areas that are witnessing rapid demand growth. The company’s innovation hubs, manufacturing facilities, and R&D centers in India contribute significantly to global product development. Philips India continues to expand its footprint in hospital diagnostic equipment, remote patient monitoring, and home healthcare, driven by rising healthcare awareness, aging populations, and increased adoption of technology in medical infrastructure. In the personal health segment, the company leverages its strong brand appeal and distribution network to maintain leadership in grooming, mother-and-child care, and small domestic appliances.
In the unlisted shares market, Philips India Limited is considered a premium investment opportunity due to its stable financial foundation, global backing, and presence in high-growth sectors. The company’s focus on healthcare technology places it at the intersection of two powerful trends—digitalization and rising healthcare spending. While unlisted shares typically offer limited liquidity and less transparent valuations, Philips India’s strong fundamentals, diversified revenue streams, and brand legacy add to its attractiveness. For long-term investors seeking exposure to India’s expanding healthcare and premium consumer technology sectors, Philips India Limited stands out as a well-established and resilient choice in the unlisted space.
Q:1 How do I start the process of buying Philips India Limited Unlisted Shares?Answer: To start the process, confirm your booking of Philips India Limited Unlisted Shares with us at a trading price.
Q:2 What documents do I need to provide to purchase the shares?Answer: You need to provide your client master report (CMR), PAN Card, and a Cancelled Cheque if you are not transferring funds from the bank account mentioned in the CMR.These are KYC documents required as per SEBI regulations.
Q:3 How will I receive the bank details for the payment?
Answer: We will provide you with the bank details once you confirm your booking of the shares.
Q:4 What methods of payment are accepted for purchasing shares?Answer: Payment can be made via RTGS, NEFT, IMPS, or CHEQUE TRANSFER.Please note that cash deposits are not accepted.
Q:5 Can I use any bank account to make my payment for the shares?
Answer: No, payment must be made from the same bank account to which the shares will be credited.
Q:6 Is there a specific format for transferring funds?
Answer: Yes, the payment must be done through RTGS, NEFT, IMPS, or as a cheque transfer.Ensure you do not make a cash deposit.
Q:7 What happens if I do not have a client master report (CMR)?
Answer: If you do not have a CMR, you can ask your broker to provide it, as it is a necessary document for the transaction.
Q:8 Why are KYC documents required for buying shares?Answer: KYC documents are required as per SEBI regulations to verify your identity and ensure compliance with legal requirements for trading in unlisted shares.